Sponsored Webinar | The Evolving Landscape of Temporary Wound Coverage: Clinical Evidence and Experience with PermeaDerm

Join the American Burn Association for an in-depth webinar examining emerging approaches to temporary wound coverage in burn care. This session will explore the clinical role of PermeaDerm®, a temporary biosynthetic wound matrix designed to provide an alternative to human cadaveric allograft while addressing challenges related to availability, cost, storage, and preparation. Speakers will present findings from the PermeaDerm-I randomized controlled trial, including clinical outcomes, economic considerations, and histological evaluation. Attendees will gain valuable insight into how temporary biosynthetic wound coverage may support staged wound management and optimize resource utilization in burn reconstruction.

Attendees will gain insight into:

• The clinical applications of PermeaDerm® as a temporary biosynthetic wound matrix

• Results from the PermeaDerm-I randomized controlled trial, including patient outcomes and histological findings

• The economic impact and resource considerations of PermeaDerm® compared with traditional allograft

• Strategies for incorporating temporary wound coverage into staged burn wound management and reconstruction

Panelist:

Anju Saraswat, MD, Assistant Medical Director, Burn Center, Department of Surgery, Wake Forest School of Medicine, Winston-Salem, NC

Christina Sharon, MD, FACS, Burn Director, Baton Rouge Regional Burn Center, Baton Rouge, LA

Derek E. Bell, MD, Professor of Plastic Surgery; Professor of Orthopaedic Surgery; Kessler Burn Director, University of Rochester Medical Center, Rochester, NY

Moderator:
Tea Millan, Program Specialist, American Burn Association

Sponsor:

AVITA Medical

Target Audience:
Burn surgeons, physicians, advanced practice providers, burn care professionals, researchers, and multidisciplinary clinicians involved in acute burn management, wound care, and reconstruction.